Cronos Group Inc. (CRON) Financial Ratios
13 years of historical data (2013–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
↑
6679.09
↑+96% vs avg
5yr avg: 3410.41
30Y Low136.9·High136.9
P/B Ratio
↓
0.91
+8% vs avg
5yr avg: 0.85
30Y Low0.7·High19.9
ROE
↑
-0.8%
↓+90% vs avg
5yr avg: -8.7%
30Y Low-94%·High123%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low1.8·High1.8
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CRON Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cronos Group Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 6679.1x P/FCF, 96% above the 5-year average of 3410.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.0B | $1.0B | $779M | $796M | $957M | $1.5B | $2.4B | $2.6B | $1.8B | $1.4B | $86M |
| Enterprise Value | $222M | $223M | $-77961860 | $129M | $197M | $575M | $1.4B | $2.6B | $1.8B | $1.4B | $87M |
| P/E Ratio → | -110.61 | — | 18.36 | — | — | — | — | 1.07 | — | — | — |
| P/S Ratio | 5.24 | 5.24 | 6.62 | 9.13 | 11.04 | 22.49 | 52.23 | 110.71 | 147.67 | 420.96 | 209.28 |
| P/B Ratio | 0.91 | 0.89 | 0.70 | 0.73 | 0.84 | 1.09 | 1.43 | 1.50 | 11.52 | 19.90 | 3.44 |
| P/FCF | 6679.09 | 6683.92 | 136.90 | — | — | — | — | — | — | — | — |
| P/OCF | 38.48 | 38.50 | 41.33 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CRON EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.15 | -0.66 | 1.48 | 2.27 | 8.90 | 29.36 | 110.00 | 146.96 | 420.02 | 210.25 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | 2.24 | — | — | — |
| EV / FCF | — | 1471.33 | -13.70 | — | — | — | — | — | — | — | — |
CRON Profitability
Margins and return-on-capital ratios measuring operating efficiency
Cronos Group Inc. earns an operating margin of -1.5%. Operating margins have expanded from -97.2% to -1.5% over the past 3 years, signaling improving operational efficiency. A negative ROE of -0.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.5% | 32.5% | 21.4% | 13.7% | 17.8% | -27.3% | -55.3% | -74.1% | 51.3% | 39.1% | 359.7% |
| Operating Margin | -1.5% | -1.5% | -65.1% | -97.2% | -128.4% | -452.2% | -469.6% | -645.5% | -168.7% | -188.6% | -297.1% |
| Net Profit Margin | -4.9% | -4.9% | 34.9% | -84.8% | -194.5% | -613.5% | -156.5% | 4911.6% | -178.5% | -45.7% | -214.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.8% | -0.8% | 3.7% | -6.6% | -13.6% | -26.0% | -4.2% | 122.5% | -19.3% | -3.2% | -5.3% |
| ROA | -0.8% | -0.8% | 3.6% | -6.3% | -12.9% | -23.8% | -3.6% | 102.2% | -15.9% | -2.6% | -4.2% |
| ROIC | -0.7% | -0.7% | -16.8% | -15.7% | -20.0% | -39.9% | -13.9% | -12.2% | -14.4% | -10.1% | -5.4% |
| ROCE | -0.3% | -0.3% | -6.9% | -7.6% | -9.0% | -19.1% | -12.6% | -16.0% | -17.6% | -12.2% | -7.0% |
CRON Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $792M exceeds total debt of $2M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.10 | 0.06 | 0.12 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.69 | -0.77 | -0.61 | -0.67 | -0.66 | -0.63 | -0.01 | -0.06 | -0.04 | 0.02 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | -5212.58 | -150.60 | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -8030.00 | -6130.63 | -392.94 | 35.42 | -264.57 | -61.09 | -6.40 |
Net cash position: cash ($792M) exceeds total debt ($2M)
CRON Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Cronos Group Inc.'s current ratio of 19.59x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 18.62x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 22.54x to 19.59x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.59 | 19.59 | 18.84 | 22.54 | 14.10 | 19.86 | 6.63 | 4.73 | 1.43 | 3.39 | 1.04 |
| Quick Ratio | 18.62 | 18.62 | 18.17 | 21.81 | 13.54 | 19.25 | 6.42 | 4.61 | 0.98 | 1.85 | 0.56 |
| Cash Ratio | 17.26 | 17.26 | 17.28 | 20.81 | 12.89 | 18.48 | 6.24 | 0.99 | 0.72 | 1.17 | 0.45 |
| Asset Turnover | — | 0.16 | 0.10 | 0.08 | 0.07 | 0.05 | 0.02 | 0.01 | 0.06 | 0.04 | 0.01 |
| Inventory Turnover | 2.79 | 2.79 | 2.79 | 2.47 | 1.90 | 2.50 | 1.65 | 1.09 | 0.39 | 0.20 | -0.39 |
| Days Sales Outstanding | — | 107.97 | 92.39 | 150.11 | 131.67 | 188.22 | 203.47 | 254.10 | 174.32 | 128.51 | 94.72 |
CRON Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cronos Group Inc. returns 1.0% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 5.4% | — | — | — | — | 93.4% | — | — | — |
| FCF Yield | 0.0% | 0.0% | 0.7% | — | — | — | — | — | — | — | — |
| Buyback Yield | 1.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 1.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $385M | $386M | $381M | $377M | $370M | $352M | $343M | $172M | $177M | $78M |
Peer Comparison
Compare CRON with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CRONYou | $1B | -110.6 | — | 6679.1 | 32.5% | -1.5% | -0.8% | -0.7% | — |
 CGC | $372M | -1.6 | — | — | 24.5% | -56.8% | -61.9% | -18.2% | — |
 TLRY | $551M | -0.1 | — | — | 29.3% | -277.9% | -89.1% | -66.2% | — |
 ACB | $181M | -1.9 | — | — | 5.2% | -50.8% | -21.8% | -25.8% | — |
 IIPR | $2B | 15.2 | 10.3 | 9.7 | 88.7% | 46.7% | 6.0% | 4.3% | 2.0 |
 SMG | $4B | 26.2 | 14.1 | 13.7 | 30.6% | 10.5% | — | 13.3% | 5.5 |
 HYFM | $4M | -0.0 | — | — | 1.6% | -29.4% | -361.3% | -12.9% | — |
 MAPS | $67M | 21.5 | 1.1 | 5.0 | 87.3% | 6.7% | 1.6% | 9.1% | 1.0 |
 MO | $116B | 16.8 | 8.9 | 12.7 | 86.6% | 74.8% | — | 60.4% | 1.7 |
 PM | $278B | 24.6 | 19.0 | 26.1 | 67.1% | 36.7% | — | 33.2% | 2.9 |
 STZ | $24B | -313.7 | 9.0 | 12.6 | 51.0% | 35.5% | -0.9% | 13.0% | 3.0 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 13 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CRON — Frequently Asked Questions
Quick answers to the most common questions about buying CRON stock.
What is Cronos Group Inc.'s P/E ratio?
Cronos Group Inc.'s current P/E ratio is -110.6x. The historical average is 9.7x.
What is Cronos Group Inc.'s ROE?
Cronos Group Inc.'s return on equity (ROE) is -0.8%. The historical average is -8.6%.
Is CRON stock overvalued?
Based on historical data, Cronos Group Inc. is trading at a P/E of -110.6x. Compare with industry peers and growth rates for a complete picture.
What are Cronos Group Inc.'s profit margins?
Cronos Group Inc. has 32.5% gross margin and -1.5% operating margin.